DK653989A - Modificeret faktor vii/viia - Google Patents

Modificeret faktor vii/viia Download PDF

Info

Publication number
DK653989A
DK653989A DK653989A DK653989A DK653989A DK 653989 A DK653989 A DK 653989A DK 653989 A DK653989 A DK 653989A DK 653989 A DK653989 A DK 653989A DK 653989 A DK653989 A DK 653989A
Authority
DK
Denmark
Prior art keywords
viia
factor vii
modified factor
replacing
proteolytically
Prior art date
Application number
DK653989A
Other languages
English (en)
Other versions
DK161097C (da
DK653989D0 (da
DK161097B (da
Inventor
Else Marie Nicolaisen
Soeren Erik Bjoern
Finn Christoph Wiberg
Richard Woodbury
Original Assignee
Novo Nordisk As
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As, Zymogenetics Inc filed Critical Novo Nordisk As
Priority to DK653989A priority Critical patent/DK161097C/da
Publication of DK653989A publication Critical patent/DK653989A/da
Publication of DK653989D0 publication Critical patent/DK653989D0/da
Publication of DK161097B publication Critical patent/DK161097B/da
Application granted granted Critical
Publication of DK161097C publication Critical patent/DK161097C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
DK653989A 1987-06-25 1989-12-21 Modificeret faktor vii/viia, dna-sekvens, som koder herfor, ekspressionsvektor indeholdende en saadan dna-sekvens, celle, der er transformeret med en saadan vektor og fremgangsmaade til fremstilling af modificeret faktor vii/viia DK161097C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK653989A DK161097C (da) 1987-06-25 1989-12-21 Modificeret faktor vii/viia, dna-sekvens, som koder herfor, ekspressionsvektor indeholdende en saadan dna-sekvens, celle, der er transformeret med en saadan vektor og fremgangsmaade til fremstilling af modificeret faktor vii/viia

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DK323587A DK323587D0 (da) 1987-06-25 1987-06-25 Protein
DK323587 1987-06-25
DK8800103 1988-06-24
PCT/DK1988/000103 WO1988010295A1 (en) 1987-06-25 1988-06-24 MODIFIED FACTOR VII/VIIa
DK653989 1989-12-21
DK653989A DK161097C (da) 1987-06-25 1989-12-21 Modificeret faktor vii/viia, dna-sekvens, som koder herfor, ekspressionsvektor indeholdende en saadan dna-sekvens, celle, der er transformeret med en saadan vektor og fremgangsmaade til fremstilling af modificeret faktor vii/viia

Publications (4)

Publication Number Publication Date
DK653989A true DK653989A (da) 1989-12-21
DK653989D0 DK653989D0 (da) 1989-12-21
DK161097B DK161097B (da) 1991-05-27
DK161097C DK161097C (da) 1991-11-11

Family

ID=8120606

Family Applications (2)

Application Number Title Priority Date Filing Date
DK323587A DK323587D0 (da) 1986-11-03 1987-06-25 Protein
DK653989A DK161097C (da) 1987-06-25 1989-12-21 Modificeret faktor vii/viia, dna-sekvens, som koder herfor, ekspressionsvektor indeholdende en saadan dna-sekvens, celle, der er transformeret med en saadan vektor og fremgangsmaade til fremstilling af modificeret faktor vii/viia

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK323587A DK323587D0 (da) 1986-11-03 1987-06-25 Protein

Country Status (7)

Country Link
EP (1) EP0370036B1 (da)
JP (1) JPH03500963A (da)
AT (1) ATE76900T1 (da)
CA (1) CA1339815C (da)
DE (1) DE3871798T2 (da)
DK (2) DK323587D0 (da)
WO (1) WO1988010295A1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580560A (en) * 1989-11-13 1996-12-03 Novo Nordisk A/S Modified factor VII/VIIa
US5358932A (en) * 1989-12-29 1994-10-25 Zymogenetics, Inc. Hybrid protein C
ES2113878T3 (es) * 1989-12-29 1998-05-16 Zymogenetics Inc Proteina c hibrida.
ATE180834T1 (de) * 1990-01-29 1999-06-15 Zymogenetics Inc Antikoagulierende proteine
US7247708B2 (en) 1997-10-23 2007-07-24 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6747003B1 (en) 1997-10-23 2004-06-08 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6693075B1 (en) * 1997-10-23 2004-02-17 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
CA2739933A1 (en) 2000-02-11 2001-08-16 Bayer Healthcare Llc Factor vii or viia-like molecules
US7220837B1 (en) 2000-04-28 2007-05-22 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US7812132B2 (en) 2000-04-28 2010-10-12 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6905683B2 (en) 2000-05-03 2005-06-14 Novo Nordisk Healthcare A/G Human coagulation factor VII variants
US20030211094A1 (en) 2001-06-26 2003-11-13 Nelsestuen Gary L. High molecular weight derivatives of vitamin k-dependent polypeptides
WO2002022776A2 (en) * 2000-09-13 2002-03-21 Novo Nordisk A/S Human coagulation factor vii variants
MXPA03001984A (es) 2000-09-13 2003-08-29 Novo Nordisk Healthcare Ag Variantes de factor vii de coagulacion humano.
WO2002038162A1 (en) 2000-11-09 2002-05-16 The Scripps Research Institute MODIFIED FACTOR VIIa
CZ20032454A3 (en) * 2001-03-22 2004-03-17 Novo Nordisk Health Care Ag Coagulation factor vii derivative
CZ2004427A3 (cs) * 2001-09-27 2004-08-18 Novoánordiskáhealthácareáag Polypeptidy lidského koagulačního faktoru VII
US7052868B2 (en) 2001-09-27 2006-05-30 Novo Nordisk Healthcare A/G Human coagulation factor VII polypeptides
US6960657B2 (en) 2001-11-02 2005-11-01 Novo Nordisk Healthcare A/G Human coagulation factor VII polypeptides
JP2005512524A (ja) * 2001-11-02 2005-05-12 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト ヒト凝固第ｖｉｉ因子ポリペプチド
WO2003093465A1 (en) 2002-04-30 2003-11-13 Maxygen Holdings Ltd. FACTOR VII OR VIIa POLYPEPTIDE VARIANTS
US6911323B2 (en) 2002-09-25 2005-06-28 Novo Nordisk Healthcare A/G Human coagulation factor VII polypeptides
CA2840692A1 (en) 2002-09-30 2004-04-08 Bayer Healthcare Llc Fvii or fviia variants having increased clotting activity
CA2519873C (en) 2003-03-20 2012-12-18 Maxygen Holdings Ltd. Fvii or fviia variants
US8791070B2 (en) 2003-04-09 2014-07-29 Novo Nordisk A/S Glycopegylated factor IX
RU2373282C2 (ru) 2003-06-19 2009-11-20 Байер Хелткэр Ллк ВАРИАНТЫ ДОМЕНА GLA ФАКТОРА VII ИЛИ VIIa
ES2381110T3 (es) 2003-09-09 2012-05-23 Novo Nordisk Health Care Ag Polipéptidos de factor VII de coagulación
US20060040856A1 (en) 2003-12-03 2006-02-23 Neose Technologies, Inc. Glycopegylated factor IX
WO2006018204A1 (en) 2004-08-17 2006-02-23 Zlb Behring Gmbh Modified vitamin k dependent polypeptides
EP2975135A1 (en) 2005-05-25 2016-01-20 Novo Nordisk A/S Glycopegylated factor IX
CA2683443A1 (en) 2007-04-13 2008-10-23 Catalyst Biosciences, Inc. Modified factor vii polypeptides and uses thereof
CA2690611C (en) 2007-06-12 2015-12-08 Novo Nordisk A/S Improved process for the production of nucleotide sugars
FR2917414B1 (fr) * 2007-06-15 2012-07-13 Lab Francais Du Fractionnement Facteur vii/viia humain modifie et composition pharmaceutique contenant celui-ci
TWI465247B (zh) 2008-04-11 2014-12-21 Catalyst Biosciences Inc 經修飾的因子ｖｉｉ多肽和其用途
NO2440239T3 (da) 2009-06-09 2018-02-10
EP3833381B1 (en) 2019-08-15 2022-08-03 Catalyst Biosciences, Inc. Modified factor vii polypeptides for subcutaneous administration

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2461040A1 (fr) * 1979-07-09 1981-01-30 Inst Textile De France Procede et dispositif pour l'obtention d'un fil presentant sur sa longueur des zones de torsion alternativement de sens inverse
US4753879A (en) * 1984-08-27 1988-06-28 Biogen N.V. Modified tissue plasminogen activators
EP0201153A3 (en) * 1985-02-09 1987-10-07 Beecham Group Plc Modified enzyme and process for its preparation
GR860984B (en) * 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
DK43387A (da) * 1986-01-29 1987-07-30 Beecham Group Plc Fibrinolytisk enzym

Also Published As

Publication number Publication date
DK323587D0 (da) 1987-06-25
DK161097C (da) 1991-11-11
EP0370036A1 (en) 1990-05-30
DE3871798D1 (de) 1992-07-09
DK653989D0 (da) 1989-12-21
WO1988010295A1 (en) 1988-12-29
ATE76900T1 (de) 1992-06-15
DE3871798T2 (de) 1993-05-13
DK161097B (da) 1991-05-27
JPH03500963A (ja) 1991-03-07
EP0370036B1 (en) 1992-06-03
CA1339815C (en) 1998-04-14

Similar Documents

Publication Publication Date Title
DK653989A (da) Modificeret faktor vii/viia
ATE80166T1 (de) Verfahren zur isolierung rekombinanter polypeptide in biologisch aktiver form.
ATE168719T1 (de) Osteogene peptide
ATE528014T1 (de) Polypeptid mit modifizierten kunitz domains
DE59207351D1 (de) Verbesserte Aktivierung von rekombinanten Proteinen
ES2112255T3 (es) Complejos proteicos que tienen actividad del factor viii:c y su produccion.
PT81445B (pt) Processo para a dissociacao de peptideos e proteinas na ligacao metionilo
ZA894721B (en) Leader sequence inducing a post-translational modification of polypeptides in bacteria,and gene therefor
DE68927379D1 (de) Plättchen blockierende peptide
ATE339878T1 (de) Myc-bindende zinkfinger-proteine, ihre herstellung und ihre verwendung
ATE81345T1 (de) Synthetische atriale peptide.
MX167236B (es) Peptidos sinteticos de timosina -1 y metodo para su obtencion
KR840008279A (ko) 아미노산 함유지방유제의 지방미립자화 방법
EP0326490A3 (en) Synthetic peptides and mixtures thereof for detecting hiv antibodies
DE3873273D1 (de) Verfahren zur selektiven spaltung von fusionsproteinen.
ATE31418T1 (de) Arzneimittel, welche tripeptide enthalten.
FI942392A0 (fi) Peptidejä ja vasta-aineita nivelreuman hoitoon
DK34590A (da) Biologisk aktive molekyler
DK0563385T3 (da) Thrombolytisk peptid, fremstilling deraf og thrombolytisk middel
DE59109109D1 (de) Kurze Peptide mit Insulinwirkung
DE69534738D1 (de) Leukocyten-aktivierender Faktor
DE69613086D1 (de) Antigenen Peptide mit Glycinsubstitution
KR890701628A (ko) 단백질(성) 감미제의 제조
ATE82754T1 (de) Sorbin und abgeleitete peptide, die die absorption durch die mucosa erhoehen.
DE68915988D1 (de) Rekombinante Polypeptide des hämorrhagischen Fisch-Sepsis-Virus.

Legal Events

Date Code Title Description
PSP Patent surrendered